Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Pandoraon Oct 17, 2020 1:28am

265 Views

Post# 31733626

Sherri's patent

This is the patent Sherri has for dental application - I don't believe Theralase has an attachment.

The present invention describes extracts of Polygonum cuspidatum and related compositions that are capable of photodynamic inactivation (PDI) of microorganisms such as bacteria, viruses, fungi, and protozoa, and capable of killing or inactivating cancer cells. The present invention further describes methods of using said Polygonum cuspidatum extracts and photodynamic inactivation (PDI) as a therapy for the treatment of microbial infection and as well as the use of Polygonum cuspidatum extract and related compositions as photodynamic therapy agents for the treatment of cancer.

SUMMARY OF THE INVENTION

In one aspect, the present invention relates to a method of killing or inactivating microorganisms, the method comprising the steps of contacting the microorganisms with a composition comprising an extract of Polygonum cuspidatum and an excipient; and irradiating the microorganisms with a source of light. In one embodiment, the method is performed in the presence of oxygen. In one embodiment, the microorganisms are in the oral cavity of a subject. In one embodiment, the microorganisms are part of a biofilm. In one embodiment, the microorganisms are attached to a dental appliance. In one embodiment, the dental appliance is selected from the group consisting of orthodontic brackets, bands, buttons, bonded attachments, bonded wire, crowns, inlays, onlays, restorations, dental abutments, and dental implants. In one embodiment, the microorganisms are selected from the group consisting of as bacteria, viruses, fungi, and protozoa. In one embodiment, the microorganisms are on the surface of a tooth, in the a cavity in a tooth, on the surface of the gums, or on the mandibular or maxillary arches.

16/264,737

Polygonum Cuspidatum Extracts As Photodynamic Inactivating Agents

206204-0001-01US

Transaction History

Date	Transaction Description
10-16-2020	Notice of Allowance Data Verification Completed
10-14-2020	Examiner's Amendment Communication
10-13-2020	Interview Summary - Applicant Initiated - Telephonic